Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a 18.262\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a COC(=O)C(C)Sc1n[nH]c(=S)s1
b Cc1cccc(C(=O)N/C(=C/c2ccco2)C(=O)N2CCCCCC2)c1
c C=CCn1c(C)cc(C(=O)COC(=O)/C=C/c2c(C)nn(C3CCS(=O)(=O)C3)c2Cl)c1C
Answer: b. Cc1cccc(C(=O)N/C(=C/c2ccco2)C(=O)N2CCCCCC2)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cccc(C(=O)N/C(=C/c2ccco2)C(=O)N2CCCCCC2)c1
Cc1cccc(C(=O)N/C(=C/c2ccco2)C(=O)N2CCCCCC2)c1
N-[(E)-3-(azepan-1-yl)-1-(furan-2-yl)-3-oxoprop-1-en-2-yl]-3-methylbenzamide